News 2023-06-23
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
Moreover, Porton also started production in its Drug Product cdmo and cell and gene therapy CDMO commercialization facilities. It also began implementing the APS (Advanced Planning and Scheduling) to boost the efficiency in production scheduling and order fulfillment and promote transparency in capacity planning management.
All these production and operation efforts are part of Porton’s commitment to providing high-quality services.
Others
More
News 2025-02-13
Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts
Porton Pharma Solutions is thrilled to announce its participation in several major industry events across the globe during the first and second quarters of 2025. As a leading end-to-end integrated CDMO company, Porton boasts globally advanced technology platforms and extensive project delivery experience in small molecules, peptides and oligonucleotides, ADCs (including antibodies, payload-linkers, conjugation, and drug product filling), and Advanced Therapy Medicinal Products.
News 2025-01-28
Our Incredible Journey in 2024
Under open skies, the years pass endlessly. As the sun rises, Porton welcomes a new year with sincerity and hope. Reflecting on 2024, we faced challenges together, standing strong and united, achieving great heights.
